Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stepan (SCL) Cash & Equivalents (2016 - 2025)

Stepan (SCL) has disclosed Cash & Equivalents for 16 consecutive years, with $132.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 33.13% year-over-year to $132.7 million, compared with a TTM value of $132.7 million through Dec 2025, up 33.13%, and an annual FY2025 reading of $132.7 million, up 33.13% over the prior year.
  • Cash & Equivalents was $132.7 million for Q4 2025 at Stepan, up from $99.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $236.0 million in Q1 2022 and bottomed at $99.7 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $149.0 million, with a median of $133.9 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents tumbled 54.51% in 2021, then surged 53.15% in 2022.
  • Year by year, Cash & Equivalents stood at $159.2 million in 2021, then increased by 9.15% to $173.8 million in 2022, then decreased by 25.28% to $129.8 million in 2023, then dropped by 23.23% to $99.7 million in 2024, then soared by 33.13% to $132.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for SCL at $132.7 million in Q4 2025, $99.7 million in Q4 2024, and $147.3 million in Q3 2024.